535 related articles for article (PubMed ID: 8846921)
1. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
2. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
5. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
7. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
[TBL] [Abstract][Full Text] [Related]
9. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation.
Wolf DA; Hermeking H; Albert T; Herzinger T; Kind P; Eick D
Oncogene; 1995 Jun; 10(11):2067-78. PubMed ID: 7784051
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
11. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
13. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
14. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
15. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Yu B; Lane ME; Wadler S
Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
[TBL] [Abstract][Full Text] [Related]
16. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
18. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
[TBL] [Abstract][Full Text] [Related]
19. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
